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Abstract
Rapid and specific diagnosis of malaria remains one of the main strategies to 
fight the disease. The diagnosis is made primarily by the simple and low-cost thick 
drop technique, considered the gold standard test. However, the requirement for 
good quality microscopes and well-trained personnel often lead to inaccurate 
diagnosis, especially in cases of mixed infections or low parasitemia. Although 
PCR-based tests can help in these situations, this technique requires large and 
sensitive equipments, being unsuitable for point of care (POC) settings. A myriad 
of POC diagnostic tests have being developed in the last years, relying on molecular 
methods but also on novel strategies. New platforms, miniaturization techniques, 
and multiplexing possibilities promise great potential to improve disease diag-
nostics through fast and accurate detection of cases, even at remote places. Here, 
we will address the main POC strategies developed for the diagnosis of malaria, 
 highlighting their strengths and weakness as POC applications.
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1. Introduction
Malaria is one of the deadliest diseases of poverty. It is estimated that malaria 
causes 228 million illnesses and 405 thousands deaths each year. Among the sick, 
children aged under 5 years are the most vulnerable group affected by malaria; in 
2018, they accounted for 67% (272 000) of all malaria deaths worldwide [1].
In many countries where malaria is endemic, a lack of access to adequate diag-
nostic services leads to poor health outcomes for fever patients, as well as poor 
surveillance of infections and outbreaks, and treatment monitoring [2].
To make matters worse, the appearance of antimalarial resistant parasites 
including artemisinin derivatives pose a major public health threat [3]. In addi-
tion, drugs such as the artemisinin-derivatives are more expensive, leading to 
an increased demand for patient evaluation by accurate diagnostic tests before 
 treatment [4–6].
Therefore, it has grown in the last years a general agreement that new diag-
nostic tests are needed for remote areas in malaria-endemic countries. However, 
the new tests must show improved performance over existing techniques, so that 
adequate distribution of anti-malarial drugs can effectively target the disease and 
its outbreaks, contributing to the reduction of generation of drug-resistant parasite 
strains [7].
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In malaria-endemic countries, the major hurdle for widespread access to malaria 
diagnostics is the limited health care infrastructure [8, 9]. According to the World 
Health Organization (WHO) guidelines, the useful diagnostic tool at the point of 
care (POC) is defined by some characteristics. It should be low cost, deliver sensi-
tive and accurate results in as little time as possible, run on a portable instrument 
(ideally, should be instrument-free), require minimal external power, require 
minimal training before use, and not require refrigerated reagent storage and 
transportation. These guidelines are collectively known by the acronym ASSURED 
(affordable, sensitive, specific, user-friendly, rapid and robust, equipment-free, 
and deliverable to end-users) [10]. In addition to those requirements, an ideal POC 
malaria diagnostic device should determine which species is infecting the patient, 
to establish the level of parasitemia, and be able to detect mixed or low-level 
infections.
Current POC tests for malaria include the smear microscopy and immunochro-
matographic rapid tests (RDTs). However, more sensitive and specific techniques 
based on nucleic acid amplification tests (NAAT) have been praised as the best 
choice for a successful malaria POC diagnostic test. In this work, we will review the 
status of the diagnostic technologies that have been used for malaria detection at 
POC conditions, discussing their main advantages and disadvantages in the POC 
context.
2. Currently available POC tests
2.1 Smear microscopy
Microscopy remains the gold standard for malaria diagnosis in most endemic 
areas. This technique allows the identification of different malaria-causing parasites 
(P. falciparum, P. vivax, P. malariae and P. ovale), their various parasite stages, 
including gametocytes, and the quantification of parasite density to monitor 
response to treatment [11].
There are two variations of the microscopy technique, the thick drop and the 
blood smear, both use the Giemsa dye in their preparations and are performed with 
sample of peripheral blood. Thick droop is made by placing a few drops of blood 
on a glass slide, allowing the blood to dry, and then lysing the blood (usually with 
water) before staining. The blood smear is made from a thin layer of cells and are 
fixed with methanol before reading. The thick drop allows the identification of 
lower parasitemias, by concentrating the parasites. The blood smear technique is 
more sensitive in speciating the parasites, however it does not allow the identifica-
tion of low parasitemias [12].
This technique has the great advantage of being cheap (costs approximately $ 
0.20 per sample), fast (approximately 1 hour between collection and the result, if 
performed by a skilled laboratory technicians), and does not need sophisticated 
equipment. The number of patients tested by microscopic examination increased 
an increase of 165 million tests in 2010 [13] to more than 208 million testes in 20171. 
The global total is dominated by India. The sensitivity of the optical microscopy 
technique using the thick drop method is50–500 parasites/μL, however, many 
factors may interfere with the results found in the thick drop technique, such as 
the quality of the microscope, the quality of the available staining reagents, and 
the skill of the technician. Several studies have shown that the sensitivity of the 
1 https://www.who.int/malaria/areas/diagnosis/microscopy/en/, accessed on February, 17th, 2021.
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microscopy technique may be lower in several areas of transmission depending on 
the quality of the examination and the expertise of the microscopists, which can 
increase the number of false negative results [14, 15].
2.2 Rapid diagnostic tests (RDTs)
Rapid diagnostic test (RDT) is a quick diagnostic approach to detect malaria 
among malaria-suspected patients and rule out malaria among individuals without 
malaria. RDTs detect parasite-specific antigens in a drop of fresh blood through 
lateral flow immunochromatography using antibodies to detect one or several 
antigens [16] (Figure 1).
The RDTs detect a single species (either P. falciparum or P. vivax), some detect 
multiple species (P. falciparum, P. vivax, P. malariae and P. ovale) and some further 
distinguish between P. falciparum and non-P. falciparum infection, or between 
specific species. The most commonly used antibodies react to histidine-rich pro-
tein-2 (HRP2), aldolase and Plasmodium lactate dehydrogenase (pLDH). HRP-2 is a 
marker for P. falciparum, while pLDH antibodies can be specific for P. falciparum, or 
P. vivax. Aldolase antibodies are pan-specific, detecting all types of malaria parasite 
but not differentiating between them [17].
Figure 1. 
Lateral flow assay architecture. Samples containing the analyte flow through the nitrocellulose membrane by 
capillary flow (panel A), carrying reporter antibodies (labeled with gold, latex or a fluorophore) until the 
mixture interacts with the test line (containing antibodies that bind the analyte of interest) and the control 
line (containing anti-IgG antibodies that bind to human IgG molecules)(panel B). If the control line shows a 










































Paracheck Pf - Rapid Test for 
P. falciparum Malaria Device (Ver. 3)
Orchid Biomedical 
Systems – Tulip 
Diagnostics (P) Ltd
94.0 NA 100.0 NA NA 1.4 NA 4.3 Yes
One Step test for Malaria Pf/Pan Ag 
MERISCREEN Malaria Pf/Pan Ag
Meril Diagnostics Pvt. 
Ltd
73.0 NA 99.0 NA NA 0.7 NA 0.0 No
Parascreen - Rapid test for Malaria 
Pan/Pf
Zephyr Biomedicals – 
Tulip Diagnostics (P) 
Ltd
91.0 94.3 100.0 97.1 0.0 0.7 0.0 1.4 Yes
FalciVax - Rapid test for Malaria 
Pv/Pf
Zephyr Biomedicals – 
Tulip Diagnostics (P) 
Ltd.
95.0 100.0 100.0 100.0 0.8 0.0 0.0 0.0 Yes
STANDARD Q Malaria Pf/Pv Ag Tes SD Biosensor, Inc 85.0 100.0 99.0 100.0 0.5 0.0 0.5 0.0 Yes
STANDARD Q Malaria Pf Pan Ag 
Test
SD Biosensor, Inc. 88.0 100.0 99.0 100.0 0.0 0.0 0.5 0.0 Yes
STANDARD Q Malaria Pf Ag Test SD Biosensor, Inc. 87.0 NA 99.0 NA NA 0.0 NA 0.0 Yes
First Response Malaria Antigen 
P. falciparum (HRP2) Card Test
Premier Medical 
Corporation Limited
95.0 NA 100.0 NA NA 0.7 NA 0.0 Yes
First Response Malaria Ag. pLDH/
HRP2 Combo Card Test
Premier Medical 
Corporation Limited
85.0 73.0 100.0 100.0 0.3 0.0 0.0 0.0 No





















































One Step test for Malaria Pf/Pv Ag 
MERISCREEN Malaria Pf/Pv Ag
Meril Diagnostics Pvt. 
Ltd
78.0 85.7 100.0 100.0 0.5 0.7 0.0 1.4 Yes




77.0 NA 100,0 NA NA 0.0 NA 0.0 Yes
NA = not applied; Pf = Plasmodium falciparum; Pv = Plasmodium vivax.
Table 1. 
Malaria RDT phase 2 performances in wild type clinical samples containing P. falciparum and P. vivax at low (200) and high (2000) parasite density (parasites/μL) and clean-negative samples. 
Data modified from [18].
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The RDT test is highly sensitive and specific, it is easy to perform, simple to 
interpret and the results can be read in 15–30 min. These make it suitable for 
community-level health facilitates in rural areas and other endemic situations where 
equipment and professional microscopists are not accessible. However, they have a 
limited shelf life, and need to be kept dry and away from extremes of temperature. 
They may also fail to detect malaria in cases where there are low levels of parasites 
in the blood, and false positives are possible due to cross reactions or gametocyte-
mia (infection with the sexual stage of the parasite only).
A brief comparison of WHO pre-qualified RDTs is presented in Table 2. 
WHO, in collaboration with Special Programme for Research and Training in 
Tropical Diseases (TDR), FIND, the United States Centers for Disease Control and 
Prevention (CDC) and other partners, established a protocol to measure the quality 
of malaria RDTs that are designed to diagnose P. falciparum-only through detection 
of histidine rich protein 2 (HRP2) and those designed to diagnose and distinguish 
P. falciparum and P. vivax or non-falciparum malaria. The protocol assesses the 
sensitivity and specificity of RDTs against specimen banks consisting of recombi-
nant antigens, culture-derived parasites, wild-type parasites, and parasite-negative 
blood samples, as well as the stability of RDTs at various temperatures and usage 
conditions. The protocol also describes aspects of the RDTs that affect ease of use in 
the field, and methods for recording all information in specific databases. Up-to-
data information on WHO pre-qualification policies and protocols can be found at 
WHO’s website2. Table 1 shows the malaria RDT performances in wild type  
P. falciparum and P. vivax clinical samples containing low (200 parasites /μL) and 
high (2000 parasites /μL) parasite density (parasites/μL) and clean-negative sam-
ples, an obligatory step of the WHO standardized tests [18]. The following criteria 
must be met for a product to be pre-qualified: (i) For the detection of P. falciparum 
in all transmission settings, the panel detection score should be at least 75% at 200 
parasites/μL; (ii) For the detection of P. vivax in all transmission settings, the panel 
detection score should be at least 75% at 200 parasites/μL; (iii) The false positive 
rate should be less than 10%; (iv) The invalid rate should be less than 5%.
3. Nucleic acid amplification-based tests (NAAT)
NAAT have the potential to overcome several hurdles for malaria diagnostic at 
POC, more specifically related to the detection of low limits of infection, as well as 
the ability to discriminate the species and quantify the parasitemia.
2 https://www.who.int/diagnostics_laboratory/evaluations/en/, accessed on February, 17th, 2021.
Microscopy RDT Nucleic Acid
Limit of detection (parasitemia) 50 parasites/μL > 100 parasites/μL 0.5–5 parasites/μL
Time to perform 60 min 15–20 min 2 hours
Cost $0.20 <$1 to $5 $1.50 –$20
Need for technical training Yes No Yes
Appropriate for remote field testing Yes Yes Not yet
Some data were compiled from [29, 60].
Table 2. 
Comparison of characteristics from currently commercially available malaria diagnostic methods.
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3.1 Polymerase chain reaction (PCR)
As the most known nucleic acid amplification technique, PCR has long been 
used for malaria diagnostic in laboratory settings. PCR-based malaria assays for 
laboratory use are found in many variations: conventional, nested, hydrolysis 
probe, digital, or high resolution melting [19–21].
As expected, there is a clear correlation between the level of PCR detection and 
the parasitemia of a given sample ([22] and Figure 2). The lower the parasitemia, 
the higher the detection cycle above the baseline/threshold (a value known as 
Ct). Conversely, the higher the parasitemia, the lower the Ct. Figure 1 shows the 
detection of different amounts of parasites using two instruments: a lab-based and 
a portable, hand held thermocycler, the Q3-Plus [23, 24]. The linear regressions 
show that there is no difference in performance between both instruments using 
Spearman correlation, with r2 ranging from 0.73 to 0.80, showing the viability of 
this portable platform for POC malaria diagnosis.
PCR is more sensitive than both microscopy and immunochromatographic tests. 
PCR has been found to be especially useful for identifying low-level infections 
often missed by other techniques, showing a detection limit in the range of 0.5–5 
parasites per μL of sample. PCR can detect multiple targets in the same reaction 
without losing sensitivity and specificity and can be easily parallelized in high 
throughput instruments [23, 25–28]. The higher sensitivity is achieved by target-
ing multi copy genomic regions, such as 18S ribosomal RNA gene, which might be 
present in up to 1000 copies per genome and contains enough similarity across the 
genus Plasmodium and yet contains enough specificity to discriminate the species 
[23, 25–28].
PCR has been coupled with lateral flow strips to create a simple and easy-to-
use detection method for the amplified products, called nucleic acid lateral flow 
immunoassay (NALFIA) [29, 30]. It combines the specificity of the PCR amplifica-
tion with the simplicity of lateral flow strips, using DNA capture and recognition 
sequences and antibody-based colorimetric methods to visualize the targets on 
the nitrocellulose membrane. NALFIA has been evaluated under field condition 
Figure 2. 
Spearman correlation between PCR detection cycle and parasitemia estimated by optical microscopy. Detection 
of P. falciparum or P. vivax DNA in human blood samples is plotted against the parasitemia estimated by 
optical microscopy. Samples were evaluated with two PCR instruments, the benchtop ABI7500 (applied 
Biosystems, Thermo fisher, USA) and the portable Q3-plus (ST microelectronics, Italy). Panels a and C 
show the detection of P. falciparum and P. vivax with the ABI7500. Panels B and D show the detection of 
P. falciparum and P. vivax with the Q3-plus.
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in Kenya, yielding results as sensitive and specific as laboratory PCR and a limit of 
detection of less than 3 parasites/μL [29].
However, in general, PCR reagents must be stored and transported at freezing 
temperatures (−20 °C), which is one of the main factors impairing its widespread 
use at POC settings all over the world and partially explaining why there are so 
many few available options for POC use for detection of infectious diseases. Some 
companies that have developed complete systems that use PCR, either conventional 
or nested, and melting curve analysis to detect targets of interest in POC conditions. 
However, neither has a solution targeted to malaria.
Much effort has been done to minimize or eliminate the requirement for freez-
ing temperature for storage and transportation of PCR reagents. Even though some 
progress was indeed achieved, no commercial product is yet available. Rampazzo 
and colleagues [23] showed a ready-to-use qPCR that can be stored in the reaction 
vessel at room temperature for up to 28 days without losing performance. Iglesias 
and coworkers [31] showed similar results using a nested PCR for malaria detection, 
providing a comparison with microscopy and rapid diagnostic tests. Kamau and 
colleagues also reported a ready-to-use multiplex PCR for malaria detection [32]. 
Taylor and coworkers [33] developed a portable PCR instrument that performed 
12 reactions in parallel, using lyophilized reagents and high resolution melting to 
detect and differentiate Plasmodium parasites, however with low sensitivity. Sun 
and colleagues [34] were able to pre-store the reagents in a portable device for rapid 
detection of Campylobacter sp. DNA. However, despite the availability of these 
technologies, we are unaware of a commercial product for malaria diagnosis that 
make use of them.
3.2 Isothermal amplification methods
Loop-mediated isothermal amplification (LAMP) is the most common iso-
thermal amplification technique, although other methods have been developed in 
the last years. Other common isothermal methods, developed after the pioneering 
technique of the rolling circle amplification [35], are recombinase polymerase 
amplification (RPA), nucleic acid sequence-based amplification (NASBA), helicase-
dependent amplification (HDA), strand displacement amplification (SDA), and 
even transcription mediated amplification (TMA) [36–42].
LAMP uses a complex set of four primers that bind to the region of interest and 
its boundaries and, after the initial amplification, create a secondary stem-and-loop 
structure that serves as a binding site constantly open for a new set of primers to 
anneal and keep the amplification happening [41, 43]. Amplification by LAMP 
involves two main repetitive steps of elongation by loop primers: the self-elongation 
step, where the template is elongated from the stem loop structure that was formed 
at the 3′ end, and the elongation step, where the formation of the new PCR product 
actually happens, polymerizing from the primers. That way, the end product is 
not a single band, but a series of concatamers of different sizes, all containing an 
amplified sequence of the target. Usually LAMP is performed at 55–65 °C by the 
enzyme Bst, from Bacillus stearothermophilus, and can use either RNA or DNA as 
templates. The requirement for a single stable temperature is a positive feature for a 
POC assay [41, 43].
Yamamura and colleagues have developed a rapid diagnostic solution for malaria 
by using DNA extraction through FTA paper, combined with a LAMP assay and 
melting curve analysis [44]. Although the solution was analyzed with real samples, 
the analyses were performed in the lab and not at the POC, so the protocol remains 
promising until tested in field conditions.
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A complete technological solution able to extract DNA, amplify and detect spe-
cific DNA sequences from malaria parasites was published [43, 45]. The presented 
an origami device that vertically processed the sample coupled with a microfluidic 
lateral flow LAMP amplification and detection platform. The platform was able to 
detect the presence of the malaria parasite in 98% of infected individuals, with a 
better performance than standard POC tests, such as optical microscopy and com-
mercial rapid immunochromatographic tests, which detected the parasite in 86 and 
83% of the cases, respectively [43, 45].
A high throughput LAMP assay for malaria detection has been shown to work in 
field conditions, with a clinically relevant sensitivity and, importantly, low cost per 
analysis [46]. It needs to be evaluated on asymptomatic patients, but it remains one 
of the most promising candidates for a true POC test.
LAMP has also been coupled with a MiniION sequencer, being able to amplify a 
genomic target and then differentiate all five Plasmodium species. The procedure is 
sensitive enough to determine the C580Y mutation of P. falciparum, which confers 
protection against artemisinin and is an emerging threat for malaria eradication 
efforts. Although the procedure is relatively long because it is necessary to pre-
pare the sequencing library, it is very versatile and shows great potential for POC 
 settings [47, 48].
Detection of PCR-amplified products by lateral flow strips has been used 
for detection of malaria parasites in field samples [29]. In that work, DNA was 
extracted using a commercial kit. However, considering the difficulties of DNA 
extraction in the field, we believe that LAMP is the most suitable amplification 
technique to be conjugated with lateral flow strips as a feasible tool to be imple-
mented in POC settings, and it should be further evaluated. Indeed, a meta-analysis 
of diagnostic accuracy of LAMP methods revealed that it is robust for diagnosing 
malaria, both in symptomatic and asymptomatic patients [49].
LAMP has also been used for detection of malaria parasites with a simple 1:1000 
sample dilution, thus bypassing the hurdles of nucleic acid extraction in the field 
[50]. Although the protocol is fast and showed excellent detection limits, it has not 
been tested with real samples in field conditions, and therefore its positive features 
remain to be confirmed.
Nucleic acid sequence-based amplification (NASBA) is an isothermal reaction 
that continuously cycle between the reverse transcriptase activity that copies an RNA 
sequence into a cDNA, and the activity of a polymerase for subsequent amplification. 
NASBA generates a high number of copies of the target per cycle, usually reaching 
detectable concentrations of the product faster than other isothermal methods [42].
NASBA has been used to estimate the prevalence in asymptomatic migrants 
[51], to estimate gametocytes density [52] and has been shown to have significant 
correlation with quantitative PCR [53]. Because of its great potential for detecting 
low-level infections, NASBA has been proposed to be a good alternative to micros-
copy, especially in low prevalence areas [29, 37]. However, NASBA has not been 
tested in field conditions, so its performance remains to be evaluated.
4. Microfluidics and other new technologies
In recent year, biological research questions have become the center of conver-
gence of several scientific disciplines, such as physics and engineering, joining the 
early partner chemistry.
Microfluidics is a general term for engineering techniques that leverage on 
physics forces at the micro scale to enable the miniaturization, simplification and 
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automation of complicated analytical processes, while consuming less reagents, 
minimizing waste, and requiring less supporting instrumentation. Working at 
the microscale, microfluidic devices are portable, easy-to-use, self-contained, and 
low-cost diagnostic devices that allow the precise manipulation of minute amounts 
of liquids to be manipulated by miniaturized structures, such as micropumps, 
micromixers, microtweezers, and microvalves. Most attractive features of microflu-
idic technology for POC applications are the low volume of reagents required, faster 
reaction times, and compact/portable platforms [54, 55].
Microfluidics can be divided in conventional and paper-based assays. 
Conventional microfluidics focuses on miniaturizing regular laboratory protocols, 
with a special emphasis on integration of all necessary elements for the diagnostic 
reaction into stand-alone systems [54, 56]. In conventional microfluidic systems, 
liquid control can be exerted by acoustic, mechanical, magnetic, as well as capil-
lary and centrifugal forces. Paper-based systems, on the other hand, rely mostly 
on the power of capillary forces, passively controlling liquid flow via hydrophilic 
and hydrophobic interactions. However, paper-based assays can integrate sample 
preparation and pre-concentration more easily than conventional microfluidic 
systems [56].
Mao and colleagues developed a portable multiplex microfluidic array system, 
which used LAMP to simultaneously amplify and detect malaria-related Anopheles 
and Plasmodium species. The system used a simple color change to discriminate 
positive from negative results [57].
Among the microfluidic devices, the centrifugal microfluidic device or lab-on-a-
disc (LOAD) has advanced remarkably due to simple operation by rotation, allowing 
for total integration of protocol steps, and high-throughput capability. LOAD devices 
have been extensively used for molecular diagnostic assays [58]. Among many targets 
and applications, one stands out relative to our goals in this text. Choi and colleagues 
developed a platform consisting of a disposable centrifugal disc and a compact 
instrument able to perform real time PCR for malaria diagnosis with a relevant limit 
of detection [59]. Although this and other platforms showed great promise towards 
POC applications, they have not been tested in field conditions [58].
4.1 DNA-based capture molecules
Aptamers, also known as ‘chemical antibodies’, are short single-stranded oli-
gonucleotides, either DNA- or RNA-based, obtained from synthetic libraries by a 
process called ‘systematic evolution of ligands by exponential enrichment (SELEX)’, 
that fold into distinct tertiary structures and are able to bind to the target with high 
affinity and specificity. Aptamer-coated surfaces, such as beads, sensors, or micro 
channels have been used to capture malaria parasites, which then can be detected by 
several techniques.
Fraser and colleagues developed a portable biosensor with a colorimetric 
approach to detect P. falciparum LDH in a device with three separate microfluidic 
chambers, obtaining high sensitivity and specificity [60]. Aptamers against other 
proteins, such as pGDH, PfEMP1, of HMGB1, have also been test in laboratory 
conditions but still largely remain as a promising approach for use in malaria-
diagnosing POC assays [55].
4.2 Non-invasive samples and detection methods
Since blood collection is an invasive technique, other samples have been evalu-
ated for their diagnostic capacity, in particular saliva and urine [61]. Although there 
11
Point-of-Care Strategies Applied to Malaria Diagnosis
DOI: http://dx.doi.org/10.5772/intechopen.96721
has been some tests in the field using saliva for serological evaluation of samples 
with reasonable success, no nucleic acid amplification protocol has been used in 
conjunction with non-invasive samples in field application to help diagnose malaria 
[61]. In addition, PCR sensitivity in these samples is lower than other POC meth-
ods, impairing their current use as samples in molecular POC tests.
Infected or healthy red blood cells (RBCs) have different paramagnetic behav-
iors, likely due to the presence of hemozoin crystallites in iRBCs [62], and thus 
can be separated using magnetic fields, taking advantage of the miniaturization of 
magnetic resonance relaxometry (MRR) [63].
In fact, iRBCs can be enriched by a variety of methods, such as margination 
[64], dielectrophoresis [65], or magnetic methods [66] [67]. Margination is 
a separation method based on the deformability of RBCs, where microfluidic 
forces within the microchannels allow for the stiffer malaria iRBCs to segregate 
towards the device’s sidewalls [62–64, 68]. Dielectrophoresis is a force exerted 
on any particle when it is subjected to a non-uniform electric field, and particle 
manipulation is dependent on physical properties of the medium and particle 
electrical properties, on particle size and shape as well as frequency of electric 
field [69]. In contrast to dielectrophoresis, microfluidic margination offers the 
convenience of not needing external electrical and magnetic fields for iRBCs 
separation. However, both dielectrophoresis as well as magnetic methods have 
been used for development of diagnostic methods for malaria infection [70]. 
Magnetic resonance relaxometry has also recently emerged as a very attractive 
technique to detect ring stage parasites, using a portable permanent magnet, with 
very encouraging results [62, 68]. However, although promising, dielectropho-
resis, magnetic resonance, or margination have not been used in POC devices for 
malaria diagnosis.
Banoth and colleagues developed a portable device that measures optical absor-
bance at 405 nm of single RBCs flowing through microfluidic channels. Variation 
in optical absorbance is then used to discriminate infected from health RBCs from 
other cellular components present in few microliters of whole blood [71]. Nam and 
coworkers produced a device with microfluidic channels decorated with a magnetic 
wire where iRBCs can be separated from hRBCs due to the paramagnetic properties 
of hemozoin with very high efficiencies [72].
Some malaria diagnostic approaches try to avoid sample collection and process-
ing altogether, such as infrared spectroscopy. Fourier transform infrared (FTIR) 
spectra are acquired directly from the biological sample without the need for any 
signal enhancer, such as dyes or reagents highlighting the targets of interest [73, 74]. 
The acquired FTIR spectra are representative of the molecular composition of the 
sample, and multivariate data analysis can be used to uncover changes in the FTIR 
spectra produced by cellular and biochemical changes induced by the presence of a 
specific pathogen [75, 76]. A work describing the use of this technique for malaria 
diagnosis employed Attenuated Total Reflection Fourier transform infrared (ATR-
FTIR) to detect gametocytes at a level 100 times lower than microscopy-based 
testing [77]. Heraud and colleagues evaluated this technique using portable infrared 
spectrometers at four regional clinics in Thailand, comparing against laboratory-
based qPCR. The analysis of 318 patients resulted in a high degree of sensitivity and 
specificity, supporting further testing in POC settings [78]. Recently, Mwanga and 
colleagues extended previous work [77] and provided the first demonstration that 
infrared spectroscopy could be coupled with supervised machine learning to accu-
rately diagnose malaria in human dried blood spots [79]. Although more extensive 
field-testing must be performed, FTIR spectroscopy is indeed a promising method 
for point of care diagnostic of malaria.
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5. The nucleic acid extraction problem
Sample preparation has always been a challenge for molecular assays as well as 
a bottleneck in translating complex molecular based tests to easy-to-use point of 
care products. Several prototype devices have been proposed and have shown good 
results in laboratory settings [80].
For nucleic acid testing, Govindarajan and colleagues reported a low cost μPAD 
for POC extraction of bacterial DNA from raw viscous samples using microfluidic 
origami. As demonstrated, Escherichia coli with a bacterial load as low as 33 CFU/
mL was reliably extracted from pig mucin (simulating sputum) and subsequently 
detected [81].
The testing of clinical samples for nucleic acids has also been performed for 
infectious disease diagnosis in resource-limited environments, for example, to 
detect Ebola virus from extracted RNA or other infectious diseases [82, 83].
A complete technological solution able to extract DNA, amplify and detect 
specific DNA sequences from malaria parasites was published [43, 45].
Gan and colleagues developed a plastic microfluidic device that integrated a fil-
ter disc for DNA extraction from samples as distinct as whole blood, dried blood on 
various paper substrates, buccal swabs, saliva, and even cigarette ends. The device 
produced DNA suitable in quantity and quality for several downstream applications 
such as sequencing, SNP evaluation, and PCR [84].
Rodriguez and colleagues integrated nucleic acid extraction with isothermal 
amplification and detection by lateral flow on a foldable paper-based device able to 
detect RNA from Influenza A (H1N1) in less than one hour [85].
Kastania and coworkers present a polymeric microfluidic chip capable of purify-
ing DNA through solid phase extraction that can be used as a stand-alone device 
or integrated in a lab-on-chip platform. The microfluidic channels were randomly 
roughened in the micro-nano scale with oxygen plasma, thereby creating high sur-
face area as well as high density of carboxyl groups (–COOH). The –COOH groups 
together with an optimized buffer are able to bind DNA on the microchannel 
surface. DNA was the washed away by changing the solution biochemical proper-
ties. DNA extracted by this device was evaluated by conventional PCR, yielding 
satisfactory results [86].
These are just some examples. For an in-depth analysis of the issues of nucleic 
acid extraction possibilities and problems, the reader is directed to excellent reviews 
on the subject [80, 87–90].
Currently, magnetic beads and solid-phase extraction are the prime choices for 
nucleic acid extraction in POC devices, even though neither is yet ready for large-
scale application [80, 91, 92]. Although both methods rely on the use of chaotropic 
agents for cell lysis and release the nucleic acids from structural proteins, washing 
steps are more efficient in beads-based methods in POC prototypes. However, some 
simplified protocols do not use beads or membranes and rely purely on both chemi-
cal and mechanical methods to denature cell membranes as well as scaffold proteins 
to release nucleic acids in adequate amounts and purity for diagnosis tests [80].
As shown above, despite extensive advances, no extraction method has made 
its way to the market of POC diagnostic solutions, and this is a major obstacle for 
nucleic acid-based assays. Although promising, integration of sample preparation, 
nucleic acid extraction, amplification and detection of genomic targets into micro-
fluidic devices has not yet achieve the maturity to have impacts on the diagnosis 
of malaria in field settings. This is clear when one considers that FTA cards are 
primarily used for sample transportation from the field to the lab, instead as part 
of a complete kit combining their sample preparation and nucleic acid capabilities 
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with the portability, not to mention sensitivity and specificity, of some of the 
techniques discussed in the prior sections of this work. We are not aware of such 
commercial kit.
A less-spoken but nonetheless quite important challenge of POC devices is waste 
disposal. Proper discard of biological waste generated by POC tests is a matter of 
concern, and open air burning might be the only option in some circumstances. 
However, the situation is more complex, since some chemical waste require special 
treatment before disposal, such as guanidine thiocyanate used in nucleic acid 
extraction protocols [93]. Developers need to take this issue in consideration when 
developing the assays and user-friendly tests.
6. Advantages and disadvantages for POC settings
An absolute requirement for identification and treatment of all parasite carriers, 
both symptomatic and asymptomatic, is inherent to all malaria elimination pro-
grams. Such identification implies that an active search for asymptomatic patients 
must be performed in POC conditions: since these patients will not look for medical 
attention, the medical team must find them. In addition, all techniques described 
in the present text have intrinsic advantages and disadvantages for application in 
POC settings, and thus each will fulfill a different aspect of the diagnostic needs, 
some better than others. Table 2 presents a brief comparison between the different 
techniques used.
Microscopy, for example, requires few and inexpensive equipments, can be 
operated under virtually any environment conditions and within a few hours of col-
lecting the blood, the microscopy test can provide valuable information. However, 
microscopy requires a very skilled professional for appropriate reading of the slides, 
which poses a problem due to the relative scarce availability. Furthermore, a review 
work found out that microscopy underestimates P. falciparum prevalence by 50% 
when compared to PCR, the gap being even more significant in low transmission 
areas [94, 95]. Likewise, Cheng and colleagues described that, on average, 69.5% 
of infections by P. vivax in areas of low transmission are detected only by PCR 
[94, 96]. Besides, microscopy results are only as reliable as the laboratories perform-
ing the tests. In non-endemic areas where the number of cases is low, the labora-
torian does not perform this test regularly, and may not be maintaining optimal 
proficiency.
RDTs, on the other hand, do not require a skilled professional and also does not 
require expensive instruments. In fact, RDTs can be used with the naked eye, which 
makes it the perfect choice for remote and hard-to-reach areas. Although they iden-
tify P. falciparum, specifically, RDTs have no species-specific capacity to identify all 
five malaria species and cannot provide information on developmental stages. The 
RDTs rely on antibody detection of parasite antigens, which are constantly under 
selective pressure and evolve over time, resulting in tests with lower affinities and, 
consequently, lower sensitivity and specificity [97]. It is important to mention that 
false-positive results are associated with persistence of PfHRP2 in peripheral blood, 
cross reactivity against human rheumatoid factor, and other infectious diseases and 
false-negative results are associated with deletions of pfhrp2 and pfhrp3 genes [98].
PCR is very sensitive and specific, as well as a very robust and well understood 
technique. Although PCR is more sensitive and specific than microscopy or RDTs, it 
has limited use as a POC diagnostic tool because of its proneness to contamination, 
relative expensive reagents, delicate instruments, the need for a stable power source 
and skilled workers [99–101]. If a portable and robust PCR instrument is developed 
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and is loaded with a malaria detecting reaction as it has been recently done [23, 33], 
then PCR might have a place in POC settings.
Compared to PCR, LAMP has the advantage of not requiring a complex and sen-
sitive instrument, using less energy and time to achieve a sensitive target detection. 
However, LAMP is prone to contamination and production of false positive results 
from non-target amplifications, which decreases the specificity. If these techno-
logical hurdles are solved, LAMP is the most promising nucleic acid amplification 
technique for use in POC settings. NASBA, a sensitive and specific amplification 
technique, also does not require a complex thermocycler. However, it is high cost, 
prone to contamination and thus production of false positives, and requires a more 
extensive sample preparation than LAMP. Although equipment-free, NASBA is still 
far from POC applications.
Non-invasive methods such as infrared detection of hemozoin are very promis-
ing due to the good results in field tests and low cost of the instrument. Together 
with LAMP, it remains one of the most promising techniques for POC malaria 
diagnosis.
Finally, yet importantly, microfluidic techniques should collaborate with any 
nucleic acid amplification technique to make feasible a robust, sensitive and specific 
malaria POC diagnostic assay. Microfluidics have the capability of overcoming most 
of the obstacles of sample preparation and adequate amplification and detection of 
genomic targets. We believe that microfluidics will be in the center of a malaria POC 
diagnostic assay within a few years.
7. Costs and cost effectiveness
When one considers the production of the tests and its associated accessories 
such as required instruments (microscope, thermal cycler, thermal block, to name 
a few) in the cost analysis, microscopy is the cheapest in the long term, after the 
cost of the microscope is diluted over the years, and qPCR is the most expensive. 
The average cost for a microscopy slide test is in the range of $0.20, while RDTs 
typically have a production cost of $0.50 to $2.00 per test, and nucleic acid amplifi-
cation techniques harbor a production cost ranging from <$1–$5 for a LAMP assay 
up to $10–$20 per qPCR or NASBA assay (Table 2). Non-invasive methods have a 
negligible cost per assay, but its overall cost is expected to be as high as qPCR tests 
due to instrument costs [30, 61].
Costs associated with the different available tests must be considered not solely 
in terms of production costs. Cost evaluation models must also include variables 
such as DALY, patient’s waiting time, cost acceptance (or ‘willingness to pay’) and, 
perhaps most importantly, adherence to the test result by patients, pharmacists, 
and health care providers, which is ultimately related to the perceived reliability of 
the test.
As discussed in the previous sections, microscopy and RDTs are the only current 
diagnostic tools adapted for use in resource-limited settings. Although samples can 
be transported to centralized laboratories to be evaluated by nucleic acid amplifica-
tion techniques, turn-around time are typically too long in rural areas of developing 
countries, defeating the purpose of point of care testing.
Some works have explored cost effectiveness of available malaria diagnostic 
options for low-resource areas: presumptive, standard microscopy, and RDTs. 
Shillcut and colleagues used a decision tree model and probabilistic sensitivity 
analysis to evaluate costs and effects of RDT-positive patients and RDT-negative 
non-malaria febrile patients [5]. The authors found that the threshold level at which 
RDTs are more cost-effective than presumptive treatment is intrinsically related to 
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the disease prevalence in the area. A health care provider can be 95% certain that 
RDTs are cost-effective relative to presumptive treatment at any prevalence below 
62%, while there is a 95% certainty that RDTs are not cost-effective if the preva-
lence if higher than 90%. Microscopy would be cost-effective with 95% certainty 
relative to presumptive treatment if prevalence were below 41%, and would not be 
effective at prevalence rates above 83%. Finally, Shillcut and colleagues determined 
that RDTs are more than 85% likely to be cost-effective relative to microscopy at 
any level of disease prevalence [5]. Although the authors clearly show that RDTs 
are cost-effective, little is known about the impact of the facility of use and adher-
ence to therapy that easy-to-use diagnostic tests might have on the patients [5, 102]. 
Similar results were observed in a deeper analysis using data from urban and rural 
areas of Nigeria [103], Kenya [104], and the Brazilian Extra-Amazon Region [105].
However, a recent study showed that patients are not always willing to pay for 
RDTs [106]. Since subsidies for artemisinin combination therapies (ACTs) already 
exist, it has been argued that similar subsidies could incentivize patients and health 
care providers to choose RDTs instead of presumptive treatment [107, 108]. Under 
that assumption, Bath and colleagues used a more complete decision tree and 
showed that subsidized RDTs could promote increased use of first-line antimalari-
als. Therefore, RDTs cost-effectiveness relative to microscopy or presumptive 
treatment would be true also in high prevalence areas, where a greater proportion of 
patients would benefit from increased first-line antimalarials use [108].
8. Conclusion
In summary, there are different methods can be employed for the diagnosis of 
human malaria. While microscopy remains the gold standard, being the mainstay 
of parasite-based diagnosis, its characteristics are inadequate for ensuring good 
sensitivity and specificity of malaria diagnosis in the field, adversely affecting 
health outcomes and optimal use of resources. An acceptable microscopy service 
is one that is both cost-effective and provides results that are consistently accu-
rate and sufficiently timely to have a direct impact on treatment. This requires a 
comprehensive and functioning quality assurance program that is lacking in most 
malaria-endemic countries. RDT tests, which require little expertise to use and 
are quality-assured from the factory, are a good alternative for malaria diagnosis 
in remote areas. However, RDTs have no species-specific capacity to identify all 
five malaria species, and the parasite can present different mutations that hinder 
this diagnosis by increasing false-negative results. Nuclei acid-based tests, on the 
contrary, are specific, sensitive, and flexible to be adapted into a POC assay. Nucleic 
acid-based POC tests have the potential to reduce inappropriate use of anti malari-
als in endemic regions, bypassing the time and expertise required for microscopic 
analysis; however, they are more expensive and have not yet been truly adapted for 
use in remote areas. However, significant advances have been made to facilitate the 
use of POC methods, so we firmly believe that, within the coming years, interdisci-
plinary partnership will certainly blend innovative knowledge in biology, chemistry 
and physics to overcome the major hurdles impairing widespread use of nucleic acid 
POC tests.
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